top
Please input keywords
OK
Database
News events
Contact us
EN
CN
JP
KR
About us
Introduction
History
Management team
Culture
Social Responsibility
Join us
Antibody R&D
Project Integrum
Antibody discovery platforms
Pipeline
Clinical pipeline
Preclinical pipeline
RenMice
RenMab
RenLite
RenNano
Animal models
Pharmacology service
Gene Editing
Collaborations
IR
Stock Information
Financial Reports
Listing Documents
Announcements & Notices
Corporate Governance
Investor Calendar
Email Alert
IR Contact
Home
News events
Downloads
Poster Downloads
Media Center
News
Events
Webinar
Publication
Downloads
Poster Downloads
Brochure
2023
SITC 2023: Development of a Preclinical CD98HC Mouse Model for Therapeutic Studies
2023
SITC 2023: Generation and Validation of Humanized GARP/TGFB1 Mice for Testing Novel Anti-human GARP Antibodies
2023
SITC 2023: Humanized CD200/CD200R Mice as a Tool for Evaluating Novel Therapeutics
2023
SITC 2023: Humanized ICOS Mice as a Novel Tool for Predicting and Monitoring T-cell-mediated Immunotherapy Response
2023
SITC 2023: Humanized NKP46 Mouse Models for Testing Novel NK Cell-based Immunotherapies
2023
SITC 2023: Preclinical CD3-based Mouse Models for Evaluation of Bi-specific T-cell Engager Antibodies
2023
SITC 2023: A Novel B2m-deficient Immunodeficient Model Expressing Human IL15 for Preclinical Evaluation of T Cell and NK Cell-based Therapies
2023
ESMO2023: Phase I open-label, dose escalation and expansion study of YH003, an anti-CD40 agonist monoclonal antibody in combination with Toripalimab in patients (pts) with advanced solid tumours
2023
IO Summit EU: YH013, a Common Light Chain Bispecific ADC Targeting EGFR and MET, Improves Preclinical Efficacy Over Its Parental Single-Targeting ADCs
1
2
3
4
5
…
12
GO